Typhoid is contagious disease caused by bacterial species, salmonella enterica and serovar typhi. It is also caused by salmonella paratyphi. A person is infected with typhoid on ingestion of water or food contaminated with stools of an individual infected with typhoid. Typhoid is also referred as typhoid fever, enteric fever, gastric fever, infantile remittent fever, abdominal typhus, nervous fever, and slow fever. Common symptoms of typhoid include, loss of appetite, lethargy, headache, diarrhea, body temperature elevated up to 104 degree Fahrenheit, presence of blood in stools, mood swings, bleeding nose, weakness, hallucinations, chills, agitation, and delirium. Diagnosis of the disease is done using complete blood count (CBC) test, blood culture, enzyme linked immunoassay (ELISA), stool culture, and platelet count tests. According to the World Health Organization (WHO), typhoid affects 16 million people worldwide every year and around 600,000 succumb to the disease globally.

Based on treatment, the global typhoid treatment market is segmented into medications and supportive therapy. Medications primarily include antibiotics such as chloramphenicol, ciprofloxacin, ceftriaxone, ampicillin, and trimethoprim-sulfamethoxazole. Supportive therapy includes intravenous (IV) fluids and intravenous electrolyte fluids. Typhoid is preventable through vaccines. The available vaccine in the typhoid treatment market are Ty21a and ViCPS. Rapidly rising morbidity rate and mortality rate of typhoid globally, increasing government initiative to control the number of typhoid cases in the country, rising health care awareness, affordable medication cost, and rapidly developing health care facilities are factors boosting the global typhoid treatment market. However, lack of early detection of typhoid and social stigma associated with the disease and its treatments especially in developing countries are factors restraining the global typhoid treatment market.

Geographically, the global typhoid treatment market is classified into five regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Currently, North America is dominating the global typhoid treatment market and is closely followed by Europe. High prevalence of typhoid, availability of highly advanced health care facilities, higher health care spending, availability of reimbursement policies, higher rate of awareness about typhoid and available treatments, and well-structured regulatory framework are some factors boosting the typhoid treatment market in North American and Europe. The market in Asia Pacific is expected to expand at a rapid pace in the near future. Factors such as rapidly developing health care infrastructure, rising disposable income, availability of highly advanced health care facilities, increasing health care spending, and government initiatives to control mortality rate of typhoid in countries in Asia Pacific are factors fuelling the typhoid treatment market in Asia Pacific. India, China, and Japan are expected to have significantly higher growth potential in the Asia Pacific typhoid treatment market owing to the rapidly rising medical tourism industry in these countries. Despite having high mortality and morbidity rates of typhoid in countries in Africa, they are expected to show low growth rate owing to the poorly developed health care facilities in these countries; therefore, development of health care facilities in these countries, is likely to boost the typhoid treatment market at a slow pace in these countries.

Major players operating in the global typhoid treatment market are GlaxoSmithKline, Bharat Biotech, Bayer, Sanofi S. A., and Pfizer.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market       

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Typhoid Treatment Market

Pre Book